{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:52:15Z","timestamp":1779342735037,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish County Council (ALF project)","award":["20130403 and 20150097"],"award-info":[{"award-number":["20130403 and 20150097"]}]},{"name":"Swedish Breast Cancer Association (BRO)"},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10549-017-4164-1","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T14:45:03Z","timestamp":1487688303000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer"],"prefix":"10.1007","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-5945","authenticated-orcid":false,"given":"Linda Holmstrand","family":"Zetterlund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Frisell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Zouzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimma","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hatschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"de Boniface","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuat","family":"Celebioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"issue":"3","key":"4164_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","volume":"222","author":"AE Giuliano","year":"1995","unstructured":"Giuliano AE, Dale PS, Turner PR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222(3):394\u2013399 discussion 9-401","journal-title":"Ann Surg"},{"issue":"9","key":"4164_CR2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599\u2013609","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"4164_CR3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927\u2013933","journal-title":"Lancet Oncol"},{"issue":"11","key":"4164_CR4","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/1097-0142(20000601)88:11<2540::AID-CNCR16>3.0.CO;2-A","volume":"88","author":"I Bedrosian","year":"2000","unstructured":"Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH et al (2000) Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88(11):2540\u20132545","journal-title":"Cancer"},{"issue":"9","key":"4164_CR5","first-page":"688","volume":"8","author":"MH Chung","year":"2001","unstructured":"Chung MH, Ye W, Giuliano AE (2001) Role for sentinel lymph node dissection in the management of large (>\u00a0or\u00a0=\u00a05\u00a0cm) invasive breast cancer. Ann Surg Oncol 8(9):688\u2013692","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"4164_CR6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/bjs.5713","volume":"94","author":"J Schule","year":"2007","unstructured":"Schule J, Frisell J, Ingvar C, Bergkvist L (2007) Sentinel node biopsy for breast cancer larger than 3\u00a0cm in diameter. Br J Surg 94(8):948\u2013951","journal-title":"Br J Surg"},{"issue":"7","key":"4164_CR7","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15(7):2483\u20132493","journal-title":"J Clin Oncol"},{"issue":"1","key":"4164_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","volume":"13","author":"L Gianni","year":"2012","unstructured":"Gianni L, Pienkowski T, Im YH, Roman L, Tseng LM, Liu MC et al (2012) Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial. Lancet Oncol 13(1):25\u201332","journal-title":"Lancet Oncol"},{"issue":"9","key":"4164_CR9","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/annonc\/mdt182","volume":"24","author":"A Schneeweiss","year":"2013","unstructured":"Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R et al (2013) Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA). Ann Oncol 24(9):2278\u20132284","journal-title":"Ann Oncol"},{"issue":"5","key":"4164_CR10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","volume":"27","author":"JM Classe","year":"2009","unstructured":"Classe JM, Bordes V, Campion L, Mignotte H, Dravet F, Leveque J et al (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 27(5):726\u2013732","journal-title":"J Clin Oncol"},{"issue":"4","key":"4164_CR11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","volume":"250","author":"KK Hunt","year":"2009","unstructured":"Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I et al (2009) Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250(4):558\u2013566","journal-title":"Ann Surg"},{"issue":"14","key":"4164_CR12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455\u20131461","journal-title":"JAMA"},{"issue":"7","key":"4164_CR13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14(7):609\u2013618","journal-title":"Lancet Oncol"},{"issue":"13","key":"4164_CR14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","volume":"32","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL et al (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: american Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32(13):1365\u20131383","journal-title":"J Clin Oncol"},{"issue":"10","key":"4164_CR15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ et al (2016) Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: implementation of Targeted Axillary Dissection. J Clin Oncol 34(10):1072\u20131078","journal-title":"J Clin Oncol"},{"key":"4164_CR16","unstructured":"Network NCC. NCCN Clinical Practice Guidelines in Oncology, Version 2.2016 Invasive Breast Cancer. 2016"},{"issue":"10","key":"4164_CR17","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ejso.2015.07.020","volume":"41","author":"TJ Nijnatten van","year":"2015","unstructured":"van Nijnatten TJ, Schipper RJ, Lobbes MB, Nelemans PJ, Beets-Tan RG, Smidt ML (2015) The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review and meta-analysis. Eur J Surg Oncol 41(10):1278\u20131287","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"4164_CR18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2015.03.014","volume":"51","author":"M van der Heiden-van der Loo","year":"2015","unstructured":"van der Heiden-van der Loo M, de Munck L, Sonke GS, van Dalen T, van Diest PJ, van den Bongard HJ et al (2015) Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment. Eur J Cancer 51(8):915\u2013921","journal-title":"Eur J Cancer"},{"issue":"3","key":"4164_CR19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SLA.0000000000000551","volume":"261","author":"JC Boughey","year":"2015","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B et al (2015) Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg 261(3):547\u2013552","journal-title":"Ann Surg"},{"issue":"1","key":"4164_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47(1):207\u2013214","journal-title":"Cancer"},{"issue":"2","key":"4164_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"3","key":"4164_CR22","first-page":"297","volume":"180","author":"DM Sataloff","year":"1995","unstructured":"Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z (1995) Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 180(3):297\u2013306","journal-title":"J Am Coll Surg"},{"issue":"6","key":"4164_CR23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Ocol 17(6):1471\u20131474","journal-title":"Ann Surg Ocol"},{"issue":"7","key":"4164_CR24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/annonc\/mdv161","volume":"26","author":"V Bossuyt","year":"2015","unstructured":"Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G et al (2015) Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol 26(7):1280\u20131291","journal-title":"Ann Oncol"},{"key":"4164_CR25","unstructured":"AJCC. Breast cancer staging AJCC 7th edition: American Joint Committee on Cancer 2009. https:\/\/cancerstaging.org\/references-tools\/quickreferences\/pages\/default.aspx. Accessed on July 2016"},{"issue":"4","key":"4164_CR26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjsurg.2005.06.004","volume":"190","author":"JL Jones","year":"2005","unstructured":"Jones JL, Zabicki K, Christian RL, Gadd MA, Hughes KS, Lesnikoski BA et al (2005) A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg 190(4):517\u2013520","journal-title":"Am J Surg"},{"issue":"12","key":"4164_CR27","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23(12):2694\u20132702","journal-title":"J Clin Oncol"},{"issue":"3","key":"4164_CR28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijsu.2009.04.012","volume":"7","author":"S Hidar","year":"2009","unstructured":"Hidar S, Bibi M, Gharbi O, Tebra S, Trabelsi A, Korbi S et al (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Int J Surg 7(3):272\u2013275","journal-title":"Int J Surg"},{"issue":"3","key":"4164_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02573060","volume":"9","author":"V Stearns","year":"2002","unstructured":"Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN (2002) Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9(3):235\u2013242","journal-title":"Ann Surg Oncol"},{"issue":"30","key":"4164_CR30","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","volume":"33","author":"JC Boughey","year":"2015","unstructured":"Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM et al (2015) Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol 33(30):3386\u20133393","journal-title":"J Clin Oncol"},{"issue":"3","key":"4164_CR31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L et al (2015) Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol 33(3):258\u2013264","journal-title":"J Clin Oncol"},{"issue":"3","key":"4164_CR32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","volume":"42","author":"V Galimberti","year":"2016","unstructured":"Galimberti V, Ribeiro Fontana SK, Maisonneuve P, Steccanella F, Vento AR, Intra M et al (2016) Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Oncol 42(3):361\u2013368","journal-title":"Eur J Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4164-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4164-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4164-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T14:16:27Z","timestamp":1658672187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4164-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["4164"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4164-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}